The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gain
- 1 April 1987
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 13 (4), 579-585
- https://doi.org/10.1016/0360-3016(87)90075-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT)British Journal of Cancer, 1986
- The radiosensitizing and toxic effects of RSU-1069 on hypoxic cells in a murine tumorInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Abnormal Response of Tumor Vasculature to Vasoactive Drugs23JNCI Journal of the National Cancer Institute, 1984
- Combined nitrogen mustard-radiation studies with a mouse tumorInternational Journal of Radiation Oncology*Biology*Physics, 1979
- New horizons in radiation oncology. Presidential address, April 13, 1978The British Journal of Radiology, 1979
- Radiobiological hypoxia of a transplanted rat tumour and the effect of treatment with cyclophosphamideEuropean Journal of Cancer (1965), 1978
- Comparison of a Vasoconstrictor and a Vasodilator in Pharmacoangiography of Bone and Soft-Tissue TumorsRadiology, 1977
- A soft agar colony assay for Lewis lung tumour and B16 melanoma taken directly from the mouseBritish Journal of Cancer, 1976
- Changes of Oxygen Tension in Tumours Induced by Vasoconstrictor and Vasodilator DrugsActa Radiologica, 1962
- Quantitative measurements of oxygen tension in normal tissues and in the tumours of patients before and after radiotherapyActa Radiologica, 1960